MAPT and Alzheimer disease: For example, some studies in N2a cells demonstrated that ApoE4 N-terminal fragments (1–272 aa) interact with mitochondria and may possibly impact on mitochondrial function and cell viability [29], as well as Aβ deposition [21] and AD-related tau pathology [11].